Coyne Scientific

Coyne Scientific, also known as CoyneSci, is a privately held biotechnology company based in Atlanta, Georgia. The company employs 7 people and generates $2.5 million in annual revenue. Coyne Scientific specializes in providing in vitro toxicity assays for pharmaceutical companies. They utilize human induced pluripotent stem cells and functional cells derived from these stem cells, sourced from a diverse pool of donors, to assess the potential safety and toxicity of pharmaceutical drugs. This approach allows them to predict the range of responses a drug might have across a target population, ultimately helping pharmaceutical companies make informed decisions about drug development. CoyneSci differentiates itself through its population-level analysis, which considers a larger and more diverse range of donors compared to traditional methods. This comprehensive approach provides pharmaceutical companies with a more accurate understanding of a drug's potential risks and benefits, enabling them to make more informed decisions about which drugs to pursue in clinical trials. For further information about Coyne Scientific and its services, please visit their website at www.coynescientific.com.